CDK9
CDK9 (cyclin dependent kinase 9, also known as PITALRE, C-2k, TAK and CDC2L4) is a serine/threonine protein kinase that regulates transcription. It is the catalytic subunit of positive transcription elongation factor b (P-TEFb), which drives RNA polymerase II from abortive to productive elongation. Browse Assay Genie's current range of CDK9 research reagents below, or read on for the biology behind the target.
CDK9 pairs with cyclin T to form the CDK9/cyclin-T complex, also called P-TEFb. This complex facilitates the transition from abortive to productive elongation by phosphorylating the C-terminal domain (CTD) of the large subunit of RNA polymerase II (POLR2A), as well as SUPT5H and RDBP. Phosphorylation of POLR2A on Ser-2 in the CTD activates transcription, and phosphorylation of the negative elongation factors DSIF and NELFE relieves their inhibitory effect. P-TEFb is inactive when held in the 7SK snRNP complex. A CDK9/cyclin-K complex also has kinase activity towards the RNA polymerase II CTD and can substitute for CDK9/cyclin-T in vitro.
Beyond elongation, CDK9 regulates cytokine-inducible transcription networks, including TNF-inducible RELA/p65 activation and IL-6-inducible STAT3 signalling. It phosphorylates EP300, MYOD1, AR and KAT5, and histone H1.4 at Ser-187, a mark associated with transcription activation. Phosphorylation of MYOD1 enhances its activity and promotes muscle differentiation, while AR phosphorylation modulates promoter selectivity and cell growth. P-TEFb is also involved in cotranscriptional histone modification, mRNA processing and mRNA export, and modulates H2B monoubiquitination, H3K4me3 and H3K36me3. The CDK9/cyclin-K complex helps maintain genome integrity during replication stress, and CDK9 promotes cardiac myocyte enlargement.
CDK9 belongs to the CMGC Ser/Thr protein kinase family, CDC2/CDKX subfamily, and is highly similar to yeast cdc28 and cdc2 gene products. Its regulatory subunits are cyclin T and cyclin K. HIV-1 Tat interacts with CDK9 and cyclin T, which suggested a possible involvement in AIDS. The CDK9 gene has mouse and rat orthologs, both named Cdk9. HGNC lists it among the cyclin dependent kinases and P-TEFb complex subunits.
CDK9 is the kinase of P-TEFb, phosphorylating the RNA polymerase II CTD, DSIF and NELFE to move transcription into productive elongation.
HIV-1 Tat interacts with CDK9 and cyclin T, and CDK9 promotes RNA synthesis in genetic programs for viral pathogenesis.
CDK9 regulates cytokine-inducible networks by aiding promoter recognition in TNF-driven RELA/p65 and IL-6-driven STAT3 signalling.
CDK9/cyclin-K supports recovery from replication stress, and P-TEFb links transcription to histone modifications such as H2Bub1, H3K4me3 and H3K36me3.
CDK9 is a protein kinase that regulates transcription. With cyclin T it forms P-TEFb, which phosphorylates the RNA polymerase II CTD and the negative elongation factors DSIF and NELFE, allowing the shift from abortive to productive elongation. It also phosphorylates transcription factors such as MYOD1 and AR.
CDK9 is also known as PITALRE, C-2k, TAK and CDC2L4, and was previously named cyclin-dependent kinase 9 (CDC2-related kinase). Its regulatory subunits are cyclin T and cyclin K. The CDK9/cyclin-T complex is called P-TEFb, or TAK/P-TEFb. UniProt notes a probable DNA repair role for isoform 2 via KU70/XRCC6.
Mouse and rat both carry a Cdk9 ortholog, and the protein is highly similar to yeast cdc28 and cdc2 gene products. HIV-1 Tat interacts with CDK9 and cyclin T, suggesting involvement in AIDS. CDK9 also promotes cardiac myocyte enlargement. Check the datasheet of any product for its validated reactivity.
Other cyclin dependent kinases, transcription-associated CDKs and CDK inhibitors with products at Assay Genie.
Gene and protein annotations from HGNC, NCBI Gene and UniProt P50750; product specifications from Assay Genie datasheets.